Quest Diagnostics Deploys Gemini AI for Patients

The Quest AI Companion operates within the company's existing MyQuest mobile app and patient portal, ensuring that all interactions are within a HIPAA-compliant environment. This is a key architectural decision, as it prevents the need for patients to input sensitive lab results into public, third-party AI tools. The system is designed to access and analyze up to five years of an individual's historical lab data from Quest to identify trends and patterns. This patient-facing tool is a direct result of a strategic collaboration between Quest Diagnostics and Google Cloud that was established in March 2025. The partnership aims to leverage Google's advanced AI and data analytics technologies to enhance customer experiences and data management. Quest's Chief Data Officer, Mark Clare, noted the company managed over 80 billion data points from more than 200 million test orders in 2024 alone, which will be fed into Google Cloud's secure infrastructure. The AI companion's primary function is to translate complex medical terminology and lab values into easy-to-understand language for patients. Beyond definitions, it can help users formulate relevant questions to ask their healthcare providers during consultations. However, the tool is explicitly positioned for educational purposes and does not provide diagnoses or treatment recommendations. This deployment is part of a larger trend of using Large Language Models (LLMs) for patient education and engagement in the healthcare sector. The goal of these applications is often to improve health literacy by making complex medical information more accessible to patients. Studies have shown that LLMs can be effective at generating patient education materials and interpreting medical information. While promising, challenges such as ensuring accuracy, avoiding bias, and maintaining readability are active areas of research and development for LLMs in medicine.